Author

E. R. Allen

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 3 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

M. Ulaszewska· 3 shared S. C. Gilbert· 3 shared T. Lambe· 3 shared A. J. Spencer· 2 shared A. Truby· 2 shared C. D. Bissett· 2 shared D. Pulido· 2 shared H. Davies· 2 shared

Activity by Year

2021-2021 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

M. Ulaszewska

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

The ChAdOx1 vectored vaccine, AZD2816, induces strong immunogenicity against SARS-CoV-2 Beta (B.1.351) and other variants of concern in preclinical studies.

A. J. Spencer, S. Morris, M. Ulaszewska, C. Powers, R. Kaliath, C. D. Bissett, A. Truby, N. Thakur, J. Newman, E. R. Allen, I. Rudiansyah, C. Lui, W. Dejnirattisai, J. Mongkolsapaya, H. Davies, , T. Lambe

bioRxiv · Jun 8, 2021Immunology

Heterologous vaccination regimens with self-amplifying RNA and Adenoviral COVID vaccines induce robust immune responses in mice

A. J. Spencer, P. F. McKay, S. Belij-Rammerstorfer, M. Ulaszewska, C. D. Bissett, K. Hu, K. Samnuan, A. K. Blakney, H. R. Sharpe, D. Wright, C. Gilbride, A. Truby, E. R. Allen, S. C. Gilbert, R. J. Shattock, T. Lambe

This study shows that heterologous vaccination with self-amplifying RNA and adenoviral SARS-CoV-2 vaccines in mice produces stronger antibody and cellular immune responses than single-dose regimens.

bioRxiv · Jan 28, 2021Immunology

Native-like SARS-CoV-2 spike glycoprotein expressed by ChAdOx1 nCoV-19/AZD1222 vaccine

Y. Watanabe, L. Mendonca, E. R. Allen, A. Howe, M. Lee, J. D. Allen, H. Chawla, D. Pulido, F. Donnellan, H. Davies, M. Ulaszewska, S. Belij-Rammerstorfer, S. Morris, A.-S. Krebs, W. Dejnirattisai, , M. Crispin

This study characterizes the structure, conformation, and glycosylation of the SARS-CoV-2 spike protein expressed by the ChAdOx1 nCoV-19/AZD1222 vaccine, confirming its native-like properties.

bioRxiv · Jan 15, 2021Microbiology